Sepsis Alliance AMR Conference 2024
Description
Sepsis Alliance’s 2023 publication, The Healthcare C-Suite AMR Market Report found that only 26% of U.S. healthcare leaders grade themselves an ‘A’ on their hospital or health system’s antimicrobial resistance (AMR) efforts. The Sepsis Alliance AMR Conference aims to provide the tools and knowledge to improve these AMR efforts.
Sepsis and the emergence of antimicrobial resistance (AMR) are intricately intertwined and pose significant challenges. Primary reliance on broad-spectrum antimicrobials is often the initial approach in sepsis treatment, yet, curbing unnecessary antimicrobial use is imperative in combating the escalating threat of AMR.
As AMR intensifies, the likelihood of infections progressing to sepsis increases, rendering sepsis cases progressively more resistant to treatment and consequently subjecting patients to adverse outcomes such as amputations and fatalities. Effectively managing this intricate clinical interplay, addressing the global AMR threat, and enhancing future outcomes necessitate collaborative efforts across sectors, ongoing innovation, and educational initiatives.
Opportunities for AMR education for clinicians, caregivers, patients, and the public are viewed by 77% of healthcare executives as necessary for combating AMR. Participation in the Sepsis Alliance AMR Conference offers a unique opportunity for attendees to explore innovative ideas, gain inspiration, and learn about practical technologies to manage sepsis and counteract the expanding challenge of antimicrobial resistance.
Topics covered will include:
- A One Health approach to combating AMR;
- Maternal and pediatric AMR;
- AMR in ambulatory and outpatient settings;
- The role of Sepsis Teams in AMS.
Learning Objectives:
At the conclusion of this event, learners will be able to:
- Explain the intricate link between sepsis and antimicrobial resistance;
- Identify tools and resources to champion responsible antimicrobial prescribing practices;
- Describe the pivotal role of healthcare executives and leadership in prioritizing, endorsing, and advancing stewardship efforts addressing antimicrobial resistance and sepsis;
- Restate methods for leadership to actively pursue inventive approaches that engage healthcare providers in initiatives aimed at tackling antimicrobial resistance and enhancing sepsis management.
FREE Nursing CE Credits Offered!
Continuing nursing education credits will be available, as will post-event access to resources, ideas, and innovations to improve sepsis care and antimicrobial stewardship. Sepsis Alliance is a Provider approved by the California Board of Registered Nursing for 9.7 contact hours, Provider Number CEP17068.
Conference Supporters:
Sepsis Alliance gratefully acknowledges the support provided for this conference by the following sponsors:
Agenda
April 10, 2024
| Time (ET) | Session Title | Presenter |
|---|---|---|
| 10:00-10:25 | Opening Remarks | |
| 10:30-11:05 | Keynote: AMR and One Health Through the Lens of Animal and Human Health (CE Session) | Jason G. Newland, MD, MEd Pediatric Infectious Diseases Washington University in St. Louis Paul J. Plummer, DVM, PhD, DACIVIM(LAIM) DECSRHM Executive Director National Institute of Antimicrobial Resistance Research and Education (NIAMRRE) |
| 11:10-11:45 | One Health in Action: Minnesota’s Collaborative Approach to Antibiotic Stewardship (CE Session) | Kristen Clark, DVM, MPH, DACVPM, CCRT Director, Minnesota One Health Antibiotic Stewardship Collaborative, Minnesota Department of Health |
| 11:50-12:20 | Recce Pharmaceuticals Sponsored Session: Beyond Existing Antibiotics: Finding a Solution to AMR and Sepsis | James Graham Managing Director & Chief Executive Officer, Recce Pharmaceuticals |
| 12:20-12:30 | Break | |
| 12:30-1:00 | Superbugged: A Personal Perspective (CE Session) | Steffanie Strathdee, PhD Associate Dean of Global Health Sciences, UCSD Department of Medicine Thomas Patterson, PhD Professor of Psychiatry, University of California, San Diego |
| 1:05-1:45 | Antibiotic Stewardship at Hospital Discharge (CE Session) | Emily Sydnor Spivak, MD, MHS, FIDSA, FSHEA
Associate Professor of Medicine, Division of Infectious Diseases University of Utah School of Medicine |
| 1:45-2:15 | bioMérieux Sponsored Session: Protecting Our Future: Preventing & Treating Sepsis in a World of Drug-Resistant Infections | Amanda L. Suchanek, Ph.D. Medical Advisor, US Medical Affairs bioMérieux |
| 2:15-2:25 | Break | |
| 2:25-3:00 | The Epidemiology of Antimicrobial Resistant Bacteria in the Pediatric Population (CE Session) | Rachel Medernach, MD, MSCI Assistant Professor Rush University Medical Center |
| 3:05-3:45 | CDC Core Elements of Hospital Antibiotic Stewardship and Hospital Sepsis Programs: What Nurses Need to Know and Do (CE Session) | Mary Lou Manning, PhD, CRNP, CIC, FAPIC, FSHEA, FAAN Professor Thomas Jefferson University |
| 3:20-3:35 | Sponsor Session (Details Coming Soon) | |
| 3:45-4:25 | Antimicrobial Stewardship: Important to All (CE Session) | Alyssa R. Letourneau, MD, MPH, FIDSA Assistant Professor of Medicine Harvard Medical School |
| 4:25-4:30 | Closing Remarks |
April 11, 2024